Although the nature of the anti-tumor effects of ESC vaccination is still not known, it is possible that it may involve expansion of an effective pool of cytotoxic T lymphocytes as well as increased trafficking and entry of CD8+ T cells into the tumor microenvironment. This evidence concerns the gene CD8A and neoplasm.